PI3Kγ signaling controls trafficking of CD8<sup>+</sup> T cells between lymphoid and non-lymphoid organs and drives hypertension in a murine model.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40595568.
- Also identified by DOI 10.1038/s41467-025-61009-4 and PMC identifier 12216620.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Activated immune cells infiltrate the vasculature during the pathophysiology of hypertension by establishing a vascular-immune interface that contributes to blood pressure dysregulation and organ failure. Many observations indicate a key role of CD8<sup>+</sup> T cells in hypertension but mechanisms regulating their activation and interplay with the cardiovascular system are still unknown. In murine model, here we show that a specific member of the phosphoinositide-3-kinases (PI3K) family of lipid kinases, PI3Kγ, is a key intracellular signaling of CD8<sup>+</sup> T cells activation and RANTES/CCL5 secretion in hypertension: CCL5-CCR5 signaling is crucial for the establishment of the vascular-immune interface in peripheral organs, lastly contributing to CD8<sup>+</sup> tissue infiltration, organ dysfunction and blood pressure elevation. Our studies identify PI3Kγ as a booster of effector CD8<sup>+</sup> T cell function, even in the absence of external stimuli. Lastly, an enhanced PI3Kγ signaling mediates the bystander activation of CD8<sup>+</sup> T cells and proves effective in transferring the hypertensive phenotype between mice.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Class Ib Phosphatidylinositol 3-Kinase
- Hypertension